Page last updated: 2024-11-03

practolol and Experimental Neoplasms

practolol has been researched along with Experimental Neoplasms in 1 studies

Practolol: A beta-1 adrenergic antagonist that has been used in the emergency treatment of CARDIAC ARRYTHMIAS.
practolol : N-(4-Hydroxyphenyl)acetamide in which the hydrogen of the phenolic hydroxy group is substituted by a 3-(isopropylaminoamino)-2-hydroxypropyl group. A selective beta blocker, it has been used in the emergency treatment of cardiac arrhythmias.

Research Excerpts

ExcerptRelevanceReference
" The widespread and chronic use of these drugs has generated a concern for their potential chronic toxicity."2.37A toxicological review of beta-adrenergic blockers. ( Fishbein, L; Jackson, CD, 1986)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jackson, CD1
Fishbein, L1

Reviews

1 review available for practolol and Experimental Neoplasms

ArticleYear
A toxicological review of beta-adrenergic blockers.
    Fundamental and applied toxicology : official journal of the Society of Toxicology, 1986, Volume: 6, Issue:3

    Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Animals; Atenolol; Cocarcinogenesis; Ethanolami

1986